Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Medicine » Cancer » Breast Cancer: Causes, Diagnosis and Treatment Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Circadian Clock: Regulations, Genetic and External Factors
$978.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Subareolar Injection May Not Always Identify the Same Sentinel Lymph Nodes as Peritumoral Injection in Breast Cancer, pp. 177-188
Tell A Friend
 
Tell someone you know about this product.
Subareolar Injection May Not Always Identify the Same Sentinel Lymph Nodes as Peritumoral Injection in Breast Cancer, pp. 177-188 $100.00
Authors:  Masakuni Noguchi, Department of Breast Oncology, Kanazawa University Hospital, Kanazawa, Japan
Abstract:
Over the past decade, the surgical management of early breast cancer has
changed from total mastectomy to breast-conserving treatment and from
routine axillary lymph node dissection to sentinel lymph node (SLN) biopsy.
Currently, SLN biopsy has become a highly utilised and widely accepted
method for surgical staging of axillary lymph nodes in breast cancer surgery in
Japan as well as in the western countries. In Japan, the number of breast
cancer patients treated with SLN biopsy is recently increasing. According to
the results of questionnaire survey on breast caner surgery, SLN biopsy was
done in 91.5% of institutions and 56% of patients in 2006 [1].
Because SLN technology has been evolving rapidly, nevertheless,
variations in techniques have been widespread, and anecdotal evidence rather
than controlled observation has been the rule. No standard procedure has been
established yet in either Japan or Western countries. There many questions
remain regarding SLN biopsy, especially those concerning the prevention of
false-negative biopsies and improvement of the yield of successful
visualisation and localisation procedures. One such controversy involves the
injection site of mapping tracer with different authors advocating peritumoral,
intradermal, subdermal, subareolar and periareolar tracer injection. It remains
unclear whether the subdermal, subareolar and peritumoral lymphatics of the
breast always drain into the same nodes and which route best simulates the
spread of breast cancer [2,3,4]. It is of course important to identify “true”
SLNs as well as to improve the identification rate of SLNs. 


Available Options:
Version:
This Item Is Currently Unavailable.
Special Focus Titles
01.Multicultural and Citizenship Awareness through Language: Cross Thematic Practices in Language Pedagogy
02.The Brainstem and Behavior
03.Sustainable Development: The Context of Use of Indigenous Plants for Local Economic Growth
04.Cancer versus Nutraceuticals
05.Fundamentals of Fuel Injection and Emission in Two-Stroke Engines
06.Free to Love: Schema Therapy for Christians
07.Textiles: Advances in Research and Applications
08.Cheese Production, Consumption and Health Benefits
09.Education in Lesotho: Prospects and Challenges
10.Work-Life Balance in the 21st Century: Perspectives, Practices, and Challenges
11.Electrical Measurements: Introduction, Concepts and Applications
12.Potassium Channels in Health and Disease

Nova Science Publishers
© Copyright 2004 - 2018

Subareolar Injection May Not Always Identify the Same Sentinel Lymph Nodes as Peritumoral Injection in Breast Cancer, pp. 177-188